Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
Tcelltech Inc.
Tcelltech Inc.
German Cancer Research Center
Sun Yat-sen University
Sichuan Baili Pharmaceutical Co., Ltd.
Therapeutic Advances in Childhood Leukemia Consortium
Celgene
Maastricht Radiation Oncology